Funds holding AN2 Therapeutics Inc
ISIN US0373261058 · United States
- Fund holders
- 15
- Of which ETFs
- 3 12 other funds
- Value held
- 4.3M $
- Share of capital
- 3.6 % of 37.7M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 733,392 | 2.5M $ | 0.00 % | 1.94 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 252,112 | 862.2K $ | 0.00 % | 0.67 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 114,783 | 126.3K $ | 0.00 % | 0.30 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 59,000 | 201.8K $ | 0.16 % | 0.16 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 53,165 | 181.8K $ | 0.02 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 48,504 | 53.4K $ | 0.13 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 30,268 | 33.3K $ | 0.08 % | as of Feb 28, 2026 ↗ | |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 26,415 | 120.2K $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 13,988 | 15.4K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 12,793 | 43.8K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 12,781 | 43.7K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 8,508 | 38.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 3,924 | 13.4K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 3,416 | 15.5K $ | 0.01 % | as of Apr 30, 2026 ↗ | |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 200 | 684 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.16 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 15 | +5 | 1,373,249 | +8.4 % |
| 2026Q1 | 10 | 0 | 1,266,712 | +0.0 % |
| 2025Q4 | 10 | -1 | 1,266,181 | -6.9 % |
| 2025Q3 | 11 | -1 | 1,359,890 | +2.6 % |
| 2025Q2 | 12 | 0 | 1,325,101 | -7.5 % |
| 2025Q1 | 12 | -2 | 1,432,535 | -0.5 % |
| 2024Q4 | 14 | -1 | 1,439,584 | +6.9 % |
| 2024Q3 | 15 | -7 | 1,347,258 | -8.9 % |
| 2024Q2 | 22 | -3 | 1,478,144 | -6.5 % |
| 2024Q1 | 25 | +7 | 1,581,354 | +24.5 % |
| 2023Q4 | 18 | 1,269,940 |
Institutional managers
49 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Vivo Capital, LLC | 3,153,640 | 10.8M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,333,713 | 8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,222,502 | 7.6M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 1,661,073 | 5.6M $ | as of Mar 31, 2026 |
| Almitas Capital LLC | 1,479,129 | 5.1M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | 3.4M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 993,671 | 3.4M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 749,035 | 2.6M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 713,845 | 2.4M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 696,181 | 2.4M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 657,200 | 2.2M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 526,315 | 1.8M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 515,754 | 1.8M $ | as of Mar 31, 2026 |
| BANK OF NOVA SCOTIA | 459,194 | 1.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 393,702 | 1.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 318,768 | 1.1M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 303,649 | 1M $ | as of Mar 31, 2026 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 298,166 | 1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 286,547 | 980.8K $ | as of Mar 31, 2026 |
| BANK OF MONTREAL /CAN/ | 260,127 | 889.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 234,187 | 800.9K $ | as of Mar 31, 2026 |
| CANTOR FITZGERALD, L. P. | 200,000 | 684K $ | as of Mar 31, 2026 |
| Seven Fleet Capital Management LP | 199,701 | 683K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 198,800 | 679.9K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 155,239 | 530.9K $ | as of Mar 31, 2026 |
Declared shareholders of AN2 Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Almitas Capital LLC | 4.10 % | 1,479,129 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding AN2 Therapeutics Inc". https://titelia.com/en/stocks/an2-therapeutics-inc-US0373261058